Founded in 1997, Cochimbec will celebrate 29 years of excellence in 2026. Its founder, Mr. Anthony Paollitto, is a respected figure in the Canadian chemistry sector. He is also one of the co-founders of ACP, representing the “A” in the company’s name—an organization that is well established and widely recognized in the market. After a career marked by innovation, scientific rigor, and the trust of his partners, Mr. Paollitto chose to pass the torch to Chaptec—a Canadian organization that shares the same values of expertise, quality, and close customer relationships. As part of this transition, Mr. Paollitto remains actively involved as a Special Advisor, ensuring continuity in knowledge, relationships, and vision that have built Cochimbec’s reputation.

Through this acquisition, Chaptec, a Canadian leader in laboratory reagents, integrates Cochimbec into its organization to strengthen and diversify its offering. This union is built on a clear and strategic logic:
- pooling scientific and technical expertise,
- expanding the product portfolio,
- consolidating a strong and specialized knowledge base,
- and creating long-term synergy for the benefit of both current and future clients. The objective is not to transform Cochimbec, but rather to unlock its full potential within a solid, agile, and forward-looking structure.

The integration of Cochimbec into the Chaptec group reinforces a strong Canadian offering, focused on the local manufacturing and distribution of chemical products intended for:
- diagnostics,
- scientific analysis,
- and medical and industrial applications. Thanks to this vertical integration, Chaptec can offer a broad range of proven, industry-trusted products, efficiently distributed nationwide through its established network. Together, Chaptec and Cochimbec are committed to a shared mission:
to deliver reliable, accessible, and Canada-rooted chemical solutions, while upholding the high standards of quality and service for which they are known.